• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amicus Therapeutics

Amicus Therapeutics

  1. Amicus Therapeutic's Fabry treatment meets goals in late-stage trial

    Amicus Therapeutic's Fabry treatment meets goals in late-stage trial

  2. UPDATE: Apple sets intraday record; PetSmart considers sale

    UPDATE: Apple sets intraday record; PetSmart considers sale

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.